MENU
+Compare
FBRX
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$15.60
Change
-$0.20 (-1.27%)
Capitalization
99.74M

FBRX Forte Biosciences Inc Forecast, Technical & Fundamental Analysis

a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer

Industry Biotechnology
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FBRX with price predictions
Jan 08, 2025

FBRX saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for FBRX moved out of overbought territory on January 07, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 39 similar instances where the indicator exited the overbought zone. In of the 39 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FBRX broke above its upper Bollinger Band on January 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 31, 2024. You may want to consider a long position or call options on FBRX as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for FBRX moved above the 200-day moving average on December 27, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FBRX advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FBRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.650) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). FBRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3060 Pegasus Park Drive
Phone
+1 310 618-6994
Employees
9
Web
https://www.fortebiorx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XYIGY17.960.03
+0.16%
Xinyi Glass Holdings Ltd.
BLQC0.03N/A
-0.14%
BlockQuarry Corp.
POAHY3.70-0.01
-0.27%
Porsche Automobile Holding SE
ANZGY18.31-0.29
-1.56%
ANZ GROUP HLDGS LTD
NGENF2.02-0.04
-1.95%
NervGen Pharma Corp.

FBRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FBRX has been loosely correlated with QSI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FBRX jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
-1.27%
QSI - FBRX
41%
Loosely correlated
-11.81%
AXON - FBRX
31%
Poorly correlated
+1.37%
CHRS - FBRX
30%
Poorly correlated
-2.11%
XCUR - FBRX
28%
Poorly correlated
+13.27%
ARRY - FBRX
28%
Poorly correlated
-0.14%
More